The majority of Americans believe abortion should be legal in all or most cases, according to an AP-NORC poll released Wednesday.
Why it matters: A year after the Supreme Courtoverturned Roe v. Wade, Americans' overall support for access to the procedure remains strong — even as red states continue to pass strict bans.
A massive data breach affecting 11 million HCA Healthcare patients provided a stark reminder this week of how often the defenses of America's largest health care organizations are hacked.
Why it matters: The hospital industry keeps sensitive personal data that is among the highest value assets on the black market — and experts predict further attacks will get harder to thwart.
Infectious disease experts are pressing Congress to commit $6 billion to incentivize the production of new treatments for drug-resistant infections as lawmakers take up broader pandemic preparedness legislation.
Why it matters:COVID-19 undid years of progress fighting superbugs that are a leading cause of deaths worldwide and that proliferated in hospitals during the health crisis.
Chidiebere Ibe,whoseillustration of a Black fetus went viral a year and a half ago, is helping launch a campaign to diversify images used in medical textbooks and diagnosis manuals.
Some experts are questioning whether a newly approved Alzheimer's drug was shown in clinical trials to be less effective on women — even though the FDA didn't flag any such concerns when it was authorized last week.
Why it matters: Nearly two-thirds of Americans living with Alzheimer's disease are female, according to the Alzheimer's Association. The $26,500 drug, Leqembi, also can cause significant side effects, and some experts question whether the benefits outweigh the risks even without accounting for any gender disparities.
The Biden administration on Tuesday released a national plan targeting the spread of xylazine, an animal tranquilizer that's increasingly laced with fentanyl and is rapidly spreading through the illegal drug trade.
Why it matters: Overdose death rates involving xylazine have skyrocketed in the past five years, but a federal strategy to fight the emerging drug threat hasn’t existed until now, leaving the response largely to a patchwork of local efforts.
As the author of New York Times' bestsellers "The Happiness Project" and "Better Than Before," Gretchen Rubin is something of an authority on staying positive.
But during a doctor's appointment for a bout with pink eye, she got a jolt from news that she had an increased risk of vision loss.
While her vision was still fine, she walked out of the office with a renewed sense of purpose. She wanted to better appreciate the sight of her husband, the smells of home, the taste of something as simple — and complex — as Heinz ketchup.
